Quarterly Consolidated Statement Of Cash Flows

TRANS GENIC GROUP INC. - Filing #7298255

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-444,955,000 JPY
-520,077,000 JPY
Interest and dividends received
305,000 JPY
145,000 JPY
Interest paid
-18,390,000 JPY
-24,297,000 JPY
Income taxes paid
-57,158,000 JPY
-55,566,000 JPY
Net cash provided by (used in) operating activities
-421,145,000 JPY
-365,546,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-73,968,000 JPY
-109,795,000 JPY
Proceeds from sale of property, plant and equipment
74,000 JPY
JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-80,382,000 JPY
JPY
Other, net
-18,350,000 JPY
-9,812,000 JPY
Net cash provided by (used in) investing activities
-174,666,000 JPY
-129,107,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
50,000,000 JPY
JPY
Repayments of long-term borrowings
-241,051,000 JPY
-260,145,000 JPY
Redemption of bonds
-7,000,000 JPY
-7,000,000 JPY
Dividends paid
-49,647,000 JPY
-82,924,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-8,813,000 JPY
JPY
Net cash provided by (used in) financing activities
378,836,000 JPY
-46,774,000 JPY
Effect of exchange rate change on cash and cash equivalents
-4,150,000 JPY
2,742,000 JPY
Net increase (decrease) in cash and cash equivalents
-221,126,000 JPY
-538,686,000 JPY
Cash and cash equivalents
2,244,975,000 JPY
2,466,101,000 JPY
2,920,760,000 JPY
3,459,447,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.